4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-047522
Chief Business Officer bought 14,705 shares at $6.80 ($99,959)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Loerop James Chief Business Officer | 2023-08-28 | Purchase | +14,705 | $6.80 | $99,959 | 21,688 | D |
| Open-market purchases · 14,705 sh · avg $6.80 · $99,959 | |||||||
Loading xslF345X05/doc4.xml…